Patent details

EN | LT

LT - REDUCTION OF INFLAMMATORY DISEASE SYMPTOMS BY SHORT PEPTIDES THAT INHIBIT SIGNALING THROUGH CD28

EN - REDUCTION OF INFLAMMATORY DISEASE SYMPTOMS BY SHORT PEPTIDES THAT INHIBIT SIGNALING THROUGH CD28

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07K 14/705
		A61K 38/17

European patent
(11)	Number of the document	3077415
(13)	Kind of document	T
(96)	European patent application number	14830734.1
	Date of filing the European patent application	2014-12-07
(97)	Date of publication of the European application	2016-10-12
(45)	Date of publication and mention of the grant of the patent	2020-02-12
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/IL2014/051067
	Date	2014-12-07

PCT application publication
(87)	Number	WO 2015/083173
	Date	2015-06-11

Inventors
(72)	KAEMPFER, Raymond, IL SHIRVAN, Anat, IL ARAD, Gila, IL

Grantee
(73)	Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Hi Tech Park Edmond Safra Campus Givat-Ram, 9139002 Jerusalem, IL Atox Bio Ltd., 3 Golda Meir Street Weizmann Science Park, 74036 Ness Ziona, IL

Title
(54)	REDUCTION OF INFLAMMATORY DISEASE SYMPTOMS BY SHORT PEPTIDES THAT INHIBIT SIGNALING THROUGH CD28
	REDUCTION OF INFLAMMATORY DISEASE SYMPTOMS BY SHORT PEPTIDES THAT INHIBIT SIGNALING THROUGH CD28